Telehealth has been well-received by patients undergoing cancer treatment or in palliative care, with high satisfaction rates reported in studies. Despite peaking in 2020 during the pandemic, telehealth encounters have been steadily declining. Experts note that telehealth adoption in oncology needs improvement, with barriers including technical issues, reimbursement uncertainties, and regulatory challenges. Research is needed to identify which cancer patients would benefit most from telemedicine. A hybrid approach combining in-person and virtual visits may be optimal for oncology care. Overall, personalized telehealth strategies and tailored solutions are key to enhancing telehealth utilization in oncology.
Source link